Fact CheckerSign in

NCT06764992Completed

Exploring Men s Prostate Cancer Genetic Risk Perceptions

Exploring Men s Prostate Cancer Genetic Risk Perceptions and Willingness to Give a Biospecimen for Genetic Risk Testing

Source: ClinicalTrials.gov · Last updated 4 Feb 2026

Brief summary (registry, in English)

The exploring men's prostate cancer genetic risk perceptions and willingness to give a biospecimen for genetic risk testing study aims to assess prostate cancer genetic risk and susceptibility beliefs among unaffected men of diverse races/ethnicities who are considering undergoing prostate cancer screening and their willingness of men to provide a biospecimen (saliva sample) and test the samples for prostate cancer aggressiveness and determine risk category based on SNP genetic profile.

Status (registry)
Completed
Study type
Observational
Enrollment
100 (actual)
First submitted
7 Jan 2025
Start date
25 Aug 2022
Primary completion date
20 Apr 2024
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
NCT number
NCT06764992

What you commit to

  • Study type: Observational
  • Participants enrolled: 100
  • From 25 Aug 2022 to the primary completion date, 20 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous personal Prostate Cancer history/diagnosis

Age

  • Under 40 years of age

Who the study is looking for

  • Racially/ethnically diverse men with emphasis on Men of African Ancestry.
  • Age 40 and older .
  • No personal prostate cancer history/diagnosis.
  • With or without family history of prostate cancer.

Age in the registry: 40 years to - · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Moffitt Cancer Center
Coordinator of this site? Confirm its status
TampaUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.